Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44?  Sandrine Florquin,

Slides:



Advertisements
Similar presentations
Pathophysiology of renal fluid retention
Advertisements

Cellular mechanisms of renal osteodystrophy
Figure 3 Extracellular stimuli to HSC activation
Renal manifestations in Fabry disease and therapeutic options
Plasmin is not protective in experimental renal interstitial fibrosis1
Management of advanced renal cancer
Volume 64, Pages S27-S32 (October 2003)
Obstructive nephropathy: Insights from genetically engineered animals
Macrophage heterogeneity, phenotypes, and roles in renal fibrosis
Marina Berenguer, Detlef Schuppan  Journal of Hepatology 
Volume 86, Issue 3, Pages (September 2014)
Progression of renal failure and hypertensive nephrosclerosis
TGF-β isoforms in renal fibrogenesis
EGFR signaling in renal fibrosis
Pathophysiology of renal fluid retention
Enyu Imai, Hideaki Nakajima, Jun-Ya Kaimori  Kidney International 
Volume 146, Issue 5, Pages (May 2014)
Michael J. Williams, Andrew D. Clouston, Stuart J. Forbes 
AOPPs and the progression of kidney disease
Volume 64, Pages S39-S45 (October 2003)
Volume 70, Issue 7, Pages (October 2006)
Gregory B. Vanden Heuvel  Kidney International 
Volume 70, Issue 11, Pages (December 2006)
Insulin resistance in African Americans
Volume 144, Issue 3, Pages (March 2013)
The renin–angiotensin–aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?  Sharon J. Nessim, Jeffrey.
The role of protein kinase C activation in diabetic nephropathy
Preservation of the kidney by carbon monoxide: a black swan phenomenon
Edmund G. Lowrie  Kidney International 
Margus Annuk, Mihkel Zilmer, Bengt Fellström
Stefan Frank, Heiko Kämpfer, Christian Wetzler, Josef Pfeilschifter 
Claudine S. Bonder, Lisa M. Ebert  Kidney International 
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Izabella Z.A. Pawluczyk, Kevin P.G. Harris  Kidney International 
Volume 64, Issue 3, Pages (September 2003)
Osteopontin in diabetic nephropathy: signpost or road?
Nitric oxide and vascular remodeling: Spotlight on the kidney
The promise of biomarkers for personalized renal cancer care
Macrophages and hypoxia in human chronic kidney disease
Endothelial dysfunction and inflammation: What is the link?
Pathogenesis of idiopathic pulmonary fibrosis (IPF).
Volume 72, Issue 2, Pages (July 2007)
Volume 70, Issue 6, Pages (September 2006)
Adenosine A2A agonists as therapy for glomerulonephritis
AGEs in foods: Do they play a role in uremia?
CD4+ T cells: a potential player in renal fibrosis
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives  Pierre Ronco, Christos Chatziantoniou 
Tubulointerstitial damage and progression of renal failure
Juan Camilo Duque, Roberto I. Vazquez-Padron  Kidney International 
Mechanisms of tubulointerstitial injury in IgA nephropathy
Kunio Matsumoto, Toshikazu Nakamura  Kidney International 
Why is proteinuria an ominous biomarker of progressive kidney disease?
Volume 63, Issue 6, Pages (June 2003)
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Clinical Gastroenterology and Hepatology
Volume 56, Pages S28-S30 (July 1999)
Charles A. Herzog  Kidney International 
Volume 65, Issue 2, Pages (February 2004)
David A. Ferenbach, David C. Kluth, Jeremy Hughes  Kidney International 
Kathryn J. Wiggins, Darren J. Kelly  Kidney International 
Volume 70, Issue 2, Pages (July 2006)
Volume 75, Issue 6, Pages (March 2009)
Renal vascular disease in the elderly
Volume 70, Issue 6, Pages (September 2006)
Volume 74, Issue 10, Pages (November 2008)
Can we cure HIV-1-associated nephropathy in transgenic mice?
Development and differentiation of endothelium
Proteinuria and hypertension with tyrosine kinase inhibitors
Volume 65, Issue 1, Pages (January 2004)
Presentation transcript:

Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44?  Sandrine Florquin, Kasper M.A. Rouschop  Kidney International  Volume 64, Pages S15-S20 (October 2003) DOI: 10.1046/j.1523-1755.64.s86.4.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Pathophysiologic mechanisms of renal damage. Abbreviations are: AT, angiotensin; PDGF, platelet-derived growth factor; VEGF, vascular endothelial growth factor; TECs, tubular epithelial cells; T, T lymphocyte; Mφ, macrophage; ECM, extracellular matrix. Kidney International 2003 64, S15-S20DOI: (10.1046/j.1523-1755.64.s86.4.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 The reciprocal effects of transforming growth factor-β1 (TGF-β1) and hepatocyte growth factor (HGF) in the cascade of tubulointerstitial damage. Black arrows, inhibitory actions; gray arrows, controversial actions; open arrows, stimulatory actions. Abbreviations are: TECs, tubular epithelial cells; ECM, extracellular matrix; MMP, matrix metalloproteinase; TIMP, tissue inhibitors of matrix metalloproteinase. Kidney International 2003 64, S15-S20DOI: (10.1046/j.1523-1755.64.s86.4.x) Copyright © 2003 International Society of Nephrology Terms and Conditions